Clinical Trials at St. Jude Children's Research Hospital
As of August 2026, 114 paid clinical trials are recruiting at St. Jude Children's Research Hospital, located at 262 DANNY THOMAS PL, MEMPHIS, TN 38105-3678, phone (901) 595-2911 in Memphis, Tennessee. Active studies at this site cover conditions such as Sickle Cell Disease, Acute Myeloid Leukemia and Neuroblastoma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
View the full facility profile →
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Memphis
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Functional Evaluation in Patients With Urea Cycle Disorders (UCD) During a Driving Task
Palliative Care Integration in Pediatric Oncology Phase 1 Clinical Trials
117 clinical trials at St. Jude Children's Research Hospital
·Clear filters·A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
A Long-term Follow-up Study in Patients Who Received BEAM-101
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
Bereaved Parent Conversations on Hope
Collaboration for Down Syndrome Progress (CDP)
Feasibility of Incorporating a Standardized Substance Use Measure With Linked-Brief Intervention Into Routine Psychosocial Care of Adult Childhood Cancer Survivors
Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients
Outcomes of Health Care Transition for AYA With a Cancer Predisposition
Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma
A Longitudinal Photo-Narrative Exploration of Hope During Phase 1/2 Clinical Trials For Pediatric Cancer
Functional Ovarian Reserve in Sickle Cell Disease
Stakeholders of Rare Diseases Informing Values In Neuroethics
CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma
Evaluation Of Cardiovascular Health Outcomes Among Survivors 2
Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Revealing Information Genuinely & Honestly Across Time - Communication Preferences Visit
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
Embryonal Tumor With Multilayered Rosettes
Positive Peers Intervention Clinical Trial
Gene Therapy Communication: Use of a Needs Assessment to Drive Decision-AIDS for Gene Therapy for Rare Diseases (GENETX)
Childhood Cancer Survivor Study
Seminar in Unwavering Empowering Presence Optimized for Rehabilitation Teams
Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Cancer: A Randomized Clinical Trial
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal Irradiation
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Common conditions studied in Memphis
- Sickle Cell Disease (18 active studies)
- Cancer (12 active studies)
- Acute Myeloid Leukemia (9 active studies)
- Neuroblastoma (8 active studies)
- Acute Lymphoblastic Leukemia (7 active studies)
- Malignant Solid Neoplasm (7 active studies)
Leading research sponsors in Memphis
- St. Jude Children's Research Hospital
- National Cancer Institute (NCI)
- Children's Oncology Group
- SWOG Cancer Research Network
- University of Tennessee
Frequently asked questions
How many paid clinical trials are currently recruiting in Memphis?
There are approximately 455 recruiting clinical trials in Memphis, Tennessee listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Memphis pay participants?
Most recruiting trials in Memphis compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Memphis?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Memphis?
The most common conditions under active study in Memphis include Sickle Cell Disease (18), Cancer (12), Acute Myeloid Leukemia (9), Neuroblastoma (8), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Memphis?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Memphis on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Memphis?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Memphis?
Recruiting research sites in Memphis include St. Jude Children's Research Hospital, Baptist Memorial Hospital and Cancer Center-Memphis, Saint Jude Children's Research Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Memphis right now?
The largest active categories in Memphis are Cancer & tumors (170), Cardiovascular (25), Neurology & pain (22). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of St. Jude Children's Research Hospital?
St. Jude Children's Research Hospital is located at 262 DANNY THOMAS PL, MEMPHIS, TN 38105-3678. Use the Google Maps link in the intro above to get directions.
How do I contact St. Jude Children's Research Hospital?
You can reach St. Jude Children's Research Hospital by phone at (901) 595-2911. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.